4.8 Article

CDK8 Kinase Phosphorylates Transcription Factor STAT1 to Selectively Regulate the Interferon Response

Journal

IMMUNITY
Volume 38, Issue 2, Pages 250-262

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2012.10.017

Keywords

-

Categories

Funding

  1. Austrian Science Fund [W1220-B09 DP, P22806-B11, SFB F28]
  2. University of Vienna [I031-B]
  3. National Cancer Institute [R01 CA127364]
  4. National Institutes of Health [T32 GM08759]
  5. Austrian Science Fund (FWF) [P22806] Funding Source: Austrian Science Fund (FWF)
  6. Austrian Science Fund (FWF) [P 22806] Funding Source: researchfish
  7. Medical Research Council [G1002523] Funding Source: researchfish
  8. MRC [G1002523] Funding Source: UKRI

Ask authors/readers for more resources

Gene regulation by cytokine-activated transcription factors of the signal transducer and activator of transcription (STAT) family requires serine phosphorylation within the transactivation domain (TAD). STAT1 and STAT3 TAD phosphorylation occurs upon promoter binding by an unknown kinase. Here, we show that the cyclin-dependent kinase 8 (CDK8) module of the Mediator complex phosphorylated regulatory sites within the TADs of STAT1, STAT3, and STAT5, including S727 within the STAT1 TAD in the interferon (IFN) signaling pathway. We also observed a CDK8 requirement for IFN-gamma-inducible antiviral responses. Microarray analyses revealed that CDK8-mediated STAT1 phosphorylation positively or negatively regulated over 40% of IFN-gamma-responsive genes, and RNA polymerase II occupancy correlated with gene expression changes. This divergent regulation occurred despite similar CDK8 occupancy at both S727 phosphorylation-dependent and -independent genes. These data identify CDK8 as a key regulator of STAT1 and antiviral responses and suggest a general role for CDK8 in STAT-mediated transcription. As such, CDK8 represents a promising target for therapeutic manipulation of cytokine responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available